16:23 EDT Nanobiotix (NBTX) files EUR75M ordinary shares offering
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NBTX:
- Nanobiotix Reports Promising Phase 2 Data for NBTXR3 in Stage 3 Inoperable Lung Cancer
- Nanobiotix price target raised to EUR 60 from EUR 34 at H.C. Wainwright
- Nanobiotix Fast-Tracks Pivotal Head and Neck Cancer Trial with FDA-Backed Protocol Shift
- Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment
- Nanobiotix price target raised to $30 from $3.50 at UBS